Literature DB >> 27083308

2-pentadecyl-2-oxazoline: Identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation.

Daniela Impellizzeri1, Marika Cordaro1, Giuseppe Bruschetta1, Rosalia Crupi1, Jennifer Pascali2, Daniele Alfonsi3, Gabriele Marcolongo3, Salvatore Cuzzocrea4.   

Abstract

N-acylethanolamines (NAEs) comprise a family of bioactive lipid molecules present in animal and plant tissues, with N-palmitoylethanolamine (PEA) having received much attention owing to its anti-inflammatory, analgesic and neuroprotective activities. 2-Pentadecyl-2-oxazoline (PEA-OXA), the oxazoline of PEA, reportedly modulates activity of N-acylethanolamine-hydrolyzing acid amidase (NAAA), which catabolizes PEA. Because PEA is produced on demand and exerts pleiotropic effects on non-neuronal cells implicated in neuroinflammation, modulating the specific amidases for NAEs (NAAA in particular) could be a way to preserve PEA role in maintaining cellular homeostasis through its rapid on-demand synthesis and equally rapid degradation. This study provides the first description of PEA-OXA in both green and roasted coffee beans and Moka infusions, and its synthesis. In an established model of carrageenan (CAR)-induced rat paw inflammation, PEA-OXA was orally active in limiting histological damage and thermal hyperalgesia 6h after CAR intraplantar injection in the right hindpaw and the accumulation of infiltrating inflammatory cells. PEA-OXA appeared to be more potent compared to ultramicronized PEA given orally at the same dose (10mg/kg). PEA-OXA markedly reduced also the increase in hindpaw myeloperoxidase activity, an index of polymorphonuclear cell accumulation in inflammatory tissues. NAAA modulators like PEA-OXA may serve to maximize availability of NAEs (e.g. PEA) while providing for recycling of the NAE components for further resynthesis.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Analgesic; Cannabinoids; Chemical synthesis; Endocannabinoid; Fatty acid; N-acylethanolamine; N-palmitoylethanolamine; Neuroinflammation

Mesh:

Substances:

Year:  2016        PMID: 27083308     DOI: 10.1016/j.phrs.2016.04.007

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  18 in total

1.  Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush.

Authors:  Enrico Gugliandolo; Ramona D'amico; Marika Cordaro; Roberta Fusco; Rosalba Siracusa; Rosalia Crupi; Daniela Impellizzeri; Salvatore Cuzzocrea; Rosanna Di Paola
Journal:  J Neuroinflammation       Date:  2018-09-14       Impact factor: 8.322

2.  2-Pentadecyl-2-Oxazoline Reduces Neuroinflammatory Environment in the MPTP Model of Parkinson Disease.

Authors:  Marika Cordaro; Rosalba Siracusa; Rosalia Crupi; Daniela Impellizzeri; Alessio Filippo Peritore; Ramona D'Amico; Enrico Gugliandolo; Rosanna Di Paola; Salvatore Cuzzocrea
Journal:  Mol Neurobiol       Date:  2018-04-14       Impact factor: 5.590

3.  Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role of Cannabinoid Receptors/ATP-Sensitive K+ Channel/p38-MAPK Signalling Pathway.

Authors:  Laís M S Neves; Elaine C D Gonçalves; Juliana Cavalli; Graziela Vieira; Larissa R Laurindo; Róli R Simões; Igor S Coelho; Adair R S Santos; Alexandre M Marcolino; Maíra Cola; Rafael C Dutra
Journal:  Mol Neurobiol       Date:  2017-10-04       Impact factor: 5.590

4.  Molecular mechanism of activation of the immunoregulatory amidase NAAA.

Authors:  Alexei Gorelik; Ahmad Gebai; Katalin Illes; Daniele Piomelli; Bhushan Nagar
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-09       Impact factor: 11.205

5.  2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation.

Authors:  Stefania Petrosino; Michela Campolo; Daniela Impellizzeri; Irene Paterniti; Marco Allarà; Enrico Gugliandolo; Ramona D'Amico; Rosalba Siracusa; Marika Cordaro; Emanuela Esposito; Vincenzo Di Marzo; Salvatore Cuzzocrea
Journal:  Front Pharmacol       Date:  2017-05-30       Impact factor: 5.810

Review 6.  Management of Traumatic Brain Injury: From Present to Future.

Authors:  Rosalia Crupi; Marika Cordaro; Salvatore Cuzzocrea; Daniela Impellizzeri
Journal:  Antioxidants (Basel)       Date:  2020-04-02

Review 7.  Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets.

Authors:  Alessio Filippo Peritore; Rosalba Siracusa; Rosalia Crupi; Salvatore Cuzzocrea
Journal:  Nutrients       Date:  2019-09-11       Impact factor: 5.717

8.  Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric Dysfunctions.

Authors:  Serena Boccella; Monica Iannotta; Claudia Cristiano; Fabio Arturo Iannotti; Fabio Del Bello; Francesca Guida; Carmela Belardo; Rosmara Infantino; Flavia Ricciardi; Mario Giannella; Antonio Calignano; Vincenzo Di Marzo; Sabatino Maione; Livio Luongo
Journal:  Front Pharmacol       Date:  2020-02-25       Impact factor: 5.810

9.  N-Palmitoylethanolamide-Oxazoline Protects against Middle Cerebral Artery Occlusion Injury in Diabetic Rats by Regulating the SIRT1 Pathway.

Authors:  Roberta Fusco; Maria Scuto; Marika Cordaro; Ramona D'Amico; Enrico Gugliandolo; Rosalba Siracusa; Alessio Filippo Peritore; Rosalia Crupi; Daniela Impellizzeri; Salvatore Cuzzocrea; Rosanna Di Paola
Journal:  Int J Mol Sci       Date:  2019-09-29       Impact factor: 5.923

10.  Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect.

Authors:  Stefania Petrosino; Marika Cordaro; Roberta Verde; Aniello Schiano Moriello; Gabriele Marcolongo; Carlo Schievano; Rosalba Siracusa; Fabiana Piscitelli; Alessio F Peritore; Rosalia Crupi; Daniela Impellizzeri; Emanuela Esposito; Salvatore Cuzzocrea; Vincenzo Di Marzo
Journal:  Front Pharmacol       Date:  2018-03-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.